Chu, Zhili
Yang, Sihui
Li, Qianru
Shang, Jianing
Ren, Zilong
Ren, Feng
Funding for this research was provided by:
Study on the mechanism of oncolytic Newcastle disease virus selective cell infection (XXBSKYZZ201919)
The mechanism of oncolytic Newcastle disease virus V protein targeting MAPK-ERK1/2 signaling pathway to regulate the proliferation of hepatocellular carcinoma cells (21A320016)
Article History
Received: 23 July 2022
Accepted: 6 April 2023
First Online: 17 April 2023
Declarations
:
: Animal testing methods were performed in accordance with relevant guidelines and regulations and handled according to standard use protocols and animal welfare regulations. The protocol in this study was approved by the Committee on the Ethics Committee of Xinxiang Medical (Permit XYLL-2021077). In addition, we confirm that all animal methods are reported in accordance with ARRIVE guidelines (ExternalRef removed).
: Not applicable.
: The authors declare no competing interests.